MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/neurintsurg-2020-016250

Медицинская библиотека · Journal of neurointerventional surgery · 2020

Clinical trial of carotid artery stenting using dual-layer CASPER stent for carotid endarterectomy in patients at high and normal risk in the Japanese population.

Imamura Hirotoshi, Sakai Nobuyuki, Matsumoto Yasushi, Yamagami Hiroshi, Terada Tomoaki, Fujinaka Toshiyuki, Yoshimura Shinichi, Sugiu Kenji, Ishii Akira, Matsumaru Yuji, Izumi Takashi, Oishi Hidenori, Higashi Toshio, Iihara Koji, Kuwayama Naoya, Ito Yasushi, Nakamura Masato, Hyodo Akio, Ogasawara Kuniaki

Клиническое исследованиеСтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

The dual-layer nitinol CASPER stent was designed to prevent plaque prolapse into its strut and periprocedural stroke.

OBJECTIVE

To conduct a clinical trial for government approval of the device in patients at either high or normal risk for carotid endarterectomy (CEA).

METHODS

Eligible patients had ≥50% symptomatic stenosis or ≥80% asymptomatic stenosis according to the North American Symptomatic Carotid Endarterectomy Trial methods (peak systolic velocity 130 and 230 cm/s on ultrasonography, respectively). The primary endpoint was the lack of major adverse events (MAEs), defined as death, stroke, and myocardial infarction within 30 days, and ipsilateral stroke within 1 year. The performance goal was set at 90.5%. MAE rates were also compared between the CEA high- and normal-risk groups.

RESULTS

140 carotid artery stenting procedures, including 40% of patients at high risk and 60% at normal risk for CEA, were performed in 13 institutes. MAEs occurred in two cases (one intraprocedural and one postprocedural stroke), and the MAE rate was 1.4%. The non-MAE rate was 98.6% according to Kaplan-Meier analysis, which was superior to the previously set performance goal. The deployment success, target lesion revascularization (TLR), in-stent restenosis, and cerebrovascular event rates were 99.3%, 2.4%, 8.5%, and 7.2%, respectively. The MAE rate in patients with normal CEA risk was 1.2%, which was similar to the high-risk CEA group, with no significant difference due to the small number of MAEs.

CONCLUSIONS

The MAE rate following use of the CASPER stent was low (1.4%). The MAE, deployment success, TLR, in-stenosis, and cerebrovascular event rates were similar to those of previous reports.

Для цитирования: Imamura Hirotoshi, Sakai Nobuyuki, Matsumoto Yasushi, Yamagami Hiroshi, Terada Tomoaki, Fujinaka Toshiyuki, Yoshimura Shinichi, Sugiu Kenji, Ishii Akira, Matsumaru Yuji, Izumi Takashi, Oishi Hidenori, Higashi Toshio, Iihara Koji, Kuwayama Naoya, Ito Yasushi, Nakamura Masato, Hyodo Akio, Ogasawara Kuniaki. Clinical trial of carotid artery stenting using dual-layer CASPER stent for carotid endarterectomy in patients at high and normal risk in the Japanese population.. Journal of neurointerventional surgery. 2020. DOI: 10.1136/neurintsurg-2020-016250.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.